Segment & Geographic Data Quant-Grade Normalized (live API) API & CSV Delivery

Heska's Business Segments

Heska's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.

Segment Data As of Q1 FY2023
Reportable Segments
2
Per the company's own filing, this quarter
Largest Segment
North America
61.8% of revenue
Total Revenue
$ 62
Consolidated, this quarter
Regions Reported
-
Geographic regions, this quarter
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/HSKA/segments
https://api.csimarket.com/api/v1/companies/HSKA/geographic
https://api.csimarket.com/api/v1/companies/HSKA/exposure
Programmatic access for models, analytics, and integration workflows.
Dataset & schema
https://api.csimarket.com/api/datasets/business_segments
https://api.csimarket.com/api/schema/business_segments
https://api.csimarket.com/api/meta/business_segments

Revenue Share by Reportable Segment - Q1 FY2023

62%largest
  • North America61.8%
  • International38.2%

Revenue by Reportable Segment - Q1 FY2023

SegmentPeriodRevenue
(Millions)
% of TotalOperating Income
North AmericaQ1 FY2023$ 3961.8%$ -9
InternationalQ1 FY2023$ 2438.2%$ -1

Revenue by Product & Service Category - Q1 FY2023

17%largest
  • Point of Care Laboratory Revenue, Consumables16.9%
  • Point of Care Laboratory Revenue, Imaging12.3%
  • Point of Care Laboratory Revenue, Lab Instruments and Other7.7%
  • OVP3.3%
  • Other Revenue, Other Pharmaceuticals, Vaccines and Diagnostic Tests1.3%

Revenue by Product & Service Category - Q1 FY2023

CategoryPeriodRevenue
(Millions)
% of Total
Point of Care Laboratory Revenue, ConsumablesQ1 FY2023$ 1116.9%
Point of Care Laboratory Revenue, ImagingQ1 FY2023$ 812.3%
Point of Care Laboratory Revenue, Lab Instruments and OtherQ1 FY2023$ 57.7%

Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.

2 more categories available

Sign in to unlock the full Heska dataset.

Description of Heska

Heska Corporation is a veterinary diagnostics and specialty pharmaceuticals company.
It was founded in 1989 and is headquartered in Loveland, Colorado.
The company's mission is to enable veterinarians to provide the best possible healthcare to pets through innovative diagnostic and treatment solutions.
Heska's product portfolio includes diagnostic instruments, blood testing kits, imaging equipment, and pharmaceuticals for animal care.
These products are designed to diagnose, treat, and prevent a wide range of medical conditions in pets.
The company operates in two segments: Core Companion Animal Health and Other Vaccines, Pharmaceuticals, and Products.
The Core Companion Animal Health segment includes blood testing instruments and supplies, digital imaging systems, software solutions, allergy testing and immunotherapy, and single-use products such as needles and syringes.
The Other Vaccines, Pharmaceuticals, and Products segment includes production and sale of injectable and inhalant anesthetics, other pharmaceutical products, and vaccines for animal health, primarily targeted at production animal markets.
In recent years, Heska has expanded its international presence, with offices in Germany, France, Spain, Italy, and other countries.
The company has also made several strategic acquisitions, such as scil animal care in 2020, to enhance its diagnostic and treatment capabilities for pets.
Overall, Heska Corporation is committed to delivering innovative solutions that improve the health and quality of life of both companion and production animals.
Heska Corporation is a prominent provider in the veterinary industry, specializing in diagnostic and specialty products aimed at enhancing animal health across various segments. With over 30 years of expertise, the company offers an extensive array of products and services tailored for veterinary clinics, animal hospitals, and research facilities worldwide. Below is an in-depth overview of Heska Corporations segments, products, and services.

Segments

Heska operates through two key reporting segments:

1. Core Companion Animal Health (CCA):
- This segment focuses on the development and provision of diagnostic products, laboratory services, and imaging solutions primarily aimed at companion animals, such as dogs and cats, along with some livestock applications.
- The products and services in this segment are pivotal for the diagnosis and detection of diseases, management of chronic health conditions, and ongoing health monitoring. The CCA includes point-of-care testing solutions, which provide immediate results for veterinarians to make informed decisions in real-time.

2. Other Vaccines & Pharmaceuticals (OVP):
- This segment encompasses a diverse range of vaccines, pharmaceuticals, and biological products tailored for livestock and poultry.
- In addition to vaccines for disease prevention, this segment includes providing contract research and manufacturing services, catering to the needs of large animal practices, commercial operations, and research initiatives. This not only supports the health of livestock but also meets the demands of food safety and animal welfare.

Products

Heskas product offerings are vast and specialized across both segments:

1. Point of Care Laboratory Instruments:
- The company offers a variety of blood analyzers, urine analyzers, and hematology analyzers. These instruments enable veterinary clinics to conduct comprehensive diagnostics quickly and efficiently, allowing for immediate results while the patient is in the clinic.

2. Digital Radiography:
- Heskas digital radiography systems provide high-resolution imaging capabilities with lower radiation exposure, allowing veterinarians to easily and accurately diagnose conditions through advanced imaging techniques.

3. Vaccines:
- Heska produces a comprehensive range of vaccines covering various species, including companion animals like dogs and cats, as well as livestock such as cattle and poultry. These vaccines serve to protect against infectious diseases, helping to maintain optimum health in animal populations.

4. Allergy Testing:
- The company offers specialized allergy testing services for companion animals, particularly dogs. This service identifies specific allergens leading to allergic reactions and skin disorders, allowing for targeted treatment options.

5. Allergy Treatment:
- In conjunction with allergy testing, Heska provides an array of allergy treatment options, including immunotherapy, medicated shampoos, and conditioners designed to alleviate symptoms and improve quality of life for allergic pets.

6. Specialty Pharmaceuticals:
- Heska develops a variety of specialty pharmaceutical products that cater to specific treatment needs. These include anesthetics, pain management medications, and antibiotics designed for chronic illness treatment, enhancing the veterinary care available to animals.

Services

To complement its product offerings, Heska provides a range of essential services:

1. Reference Laboratories:
- Heska boasts an extensive network of reference laboratories equipped with advanced technology. These facilities assist veterinary clinics in conducting high-level diagnostic testing, ensuring accurate and timely results that support effective treatment strategies.

2. Software Solutions:
- The company offers comprehensive software solutions that help veterinary professionals manage critical aspects of their practice, including patient records, appointment scheduling, billing, and inventory management. These tools aim to streamline operations and enhance the overall efficiency of veterinary practices.

3. Diagnostic Consultations:
- Heska provides diagnostic consultation services, offering clinical support to veterinary clinics. This includes assistance in interpreting diagnostic test results and developing treatment plans tailored to individual patient needs, thereby improving treatment outcomes.

Conclusion

In summary, Heska Corporation stands as a global leader in veterinary diagnostics and specialty products, dedicated to enhancing animal health through innovative, quality solutions. Its diverse portfolio, spanning laboratory diagnostics, imaging, pharmaceuticals, and allergy management, reflects a commitment to meeting the evolving needs of veterinary professionals. As the company continues to innovate, it reinforces its role as a trusted partner in animal health, striving to improve the well-being of pets and livestock alike.